--------------------------
OMB APPROVAL
--------------------------
OMB Number: 3235-0145
Expires: December 31, 2005
Estimated average burden
Hours per response...11
--------------------------
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(AMENDMENT NO. 14 )*
Presstek, Inc.
--------------------------------------------------------------------------------
(Name of Issuer)
Common Stock
--------------------------------------------------------------------------------
(Title of Class of Securities)
741113 10 4
--------------------------------------------------------------------------------
(CUSIP Number)
December 31, 2004
--------------------------------------------------------------------------------
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule
is filed:
[ ] Rule 13d-1(b)
[ ] Rule 13d-1(c)
[X] Rule 13d-1(d)
-----------
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
Persons who respond to the collection of information contained in this form are
not required to respond unless the form displays a currently valid OMB control
number.
SEC 1745 (12/02)
CUSIP NO. 741113 10 4 13G PAGE 2 OF 6 PAGES
--------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)
DR. LAWRENCE HOWARD
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [ ]
(b) [ ]
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
UNITED STATES OF AMERICA
--------------------------------------------------------------------------------
5 SOLE VOTING POWER
NUMBER OF 1,532,255 AS OF 12/31/04
SHARES --------------------------------------------------------------
BENEFICIALLY 6 SHARED VOTING POWER
OWNED BY 340,948 AS OF 12/31/04
EACH --------------------------------------------------------------
REPORTING 7 SOLE DISPOSITIVE POWER
PERSON WITH 1,532,255 AS OF 12/31/04
--------------------------------------------------------------
8 SHARED DISPOSITIVE POWER
340,948 AS OF 12/31/04
--------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,873,203 AS OF 12/31/04
--------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
[ ]
--------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
5.4%
--------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON *
IN
--------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
CUSIP NO. 741113 10 4 13G PAGE 3 OF 6 PAGES
ITEM 1.
(A) NAME OF ISSUER
Presstek, Inc.
(B) ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES
55 Executive Drive, Hudson, NH 03051-4903
ITEM 2.
(A) NAME OF PERSON FILING:
Dr. Lawrence Howard
(B) ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE:
c/o Hudson Partners, LP, 660 Madison Ave., 14th Floor, New
York, NY 10021
(C) CITIZENSHIP:
United States of America
(D) TITLE OF CLASS OF SECURITIES:
Common Stock
(E) CUSIP NUMBER:
741113 10 4
ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO SECTION 240.13D-1(B) OR
SECTIONS 240.13D-2(B) OR (C), CHECK WHETHER THE PERSON FILING IS A:
(a) [ ] Broker or dealer registered under section 15 of the Act (15
U.S.C. 78o);
(b) [ ] Bank as defined in section 3(a)(6) of the Act (15 U.S.C.
78c).
(c) [ ] Insurance company as defined in section 3(a)(19) of the Act
(15 U.S.C. 78c).
(d) [ ] Investment company registered under section 8 of the
Investment Company Act of 1940 (15 U.S.C. 80a-8).
(e) [ ] An investment adviser in accordance with section
240.13d-1(b)(1)(ii)(E);
CUSIP NO. 741113 10 4 13G PAGE 4 OF 6 PAGES
(f) [ ] An employee benefit plan or endowment fund in accordance
with section 240.13d-1(b)(1)(ii)(F);
(g) [ ] A parent holding company or control person in accordance
with section 240.13d-1(b)(1)(ii)(G);
(h) [ ] A savings associations as defined in Section 3(b) of the
Federal Deposit Insurance Act;
(i) [ ] A church plan that is excluded from the definition of an
investment company under section 3(c)(14) of the Investment
Company Act of 1940 (25 U.S.C. 80a-3);
(j) [ ] Group, in accordance with section 240.13d-1(b)(1)(ii)(J).
None of the above.
ITEM 4. OWNERSHIP.
Provide the following information regarding the aggregate number and percentage
of the class of securities of the issuer identified in ITEM 1.
(a) AMOUNT BENEFICIALLY OWNED:
Dr. Howard may be deemed to beneficially own 1,873,203 shares
of Common Stock as of December 31, 2004. Such shares were held
as follows:
Dr. Howard is the owner of 1,532,255 shares of Common Stock,
of which 27,500 are options exerciseable within 60 days of
December 31, 2004. Dr. Howard may be deemed to exert sole
voting and investment power over such securities. Dr. Howard
is also the owner of 23% of the Member Interests of a limited
liability company that is the record owner of 110,503 shares
of Common Stock. Dr. Howard's daughter owns the other 77% of
the Member Interests of the limited liability company. Dr.
Howard and Dr. Howard's wife are the Managing Members of the
limited liability company. Dr. Howard may be deemed to exert
shared voting and investment power over such securities. Dr.
Howard is also the owner of 20% of the Member Interests of
another limited liability company that is the record owner of
182,195 shares of Common Stock. Dr. Howard's daughter and son
own the other 80% of the Member Interests of the limited
liability company. Dr. Howard and Dr. Howard's wife are the
Managing Members of the limited liability company. Dr. Howard
may be deemed to exert shared voting and investment power over
such securities.
Dr. Howard's wife is the record owner of 35,000 shares of
Common Stock. Dr. Howard's wife is also the record owner, as
custodian for Dr. Howard's minor children, of 8,250 shares of
Common Stock. Dr. Howard's
CUSIP NO. 741113 10 4 13G PAGE 5 OF 6 PAGES
daughter is the record owner of 5,000 shares. Dr. Howard may
be deemed to exert shared voting and investment power over
such securities.
(b) PERCENT OF CLASS: 5.4%.
The foregoing percentage is calculated based on 34,831,786
shares of Common Stock reported by the Issuer to be
outstanding as of November 5, 2004 in its report on Form 10-Q
filed with the Securities and Exchange Commission on November
12, 2004.
(c) NUMBER OF SHARES AS TO WHICH THE PERSON HAS:
Reference is made to Items Nos. 5-9 of the Cover Sheet
ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS.
Not applicable.
ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON.
Not applicable.
ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED
THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY.
Not applicable.
ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP.
Not applicable.
ITEM 9. NOTICE OF DISSOLUTION OF GROUP.
Not applicable.
ITEM 10. CERTIFICATION.
Not applicable.
CUSIP NO. 741113 10 4 13G PAGE 6 OF 6 PAGES
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
February 10, 2005
---------------------
(Date)
/s/ Lawrence Howard
---------------------
(Signature)
Dr. Lawrence Howard
---------------------
(Name/Title)